Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-acetylcysteine on the success rate of Helicobacter pylori eradication
IRCT2012121511738N2Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in Helicobacter pylori infection, sponsored by Research Deputy of Tabriz University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication success rate. Started Apr 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT2012121511738N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012121511738N2.